公开(公告)号：US20240252547A1

公开(公告)日：2024-08-01

申请号：US18564485

申请日：2022-05-26

Applicant: CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION ,  IPS BIO, INC.

Inventor： Jihwan SONG

IPC: A61K35/30 ,  A61P9/10 ,  C12N5/0797

CPC classification number: A61K35/30 ,  A61P9/10 ,  C12N5/0623 ,  C12N2500/32 ,  C12N2500/38 ,  C12N2500/98 ,  C12N2501/115 ,  C12N2506/45 ,  C12N2533/52

Abstract: A pharmaceutical composition for preventing or treating a stroke, the pharmaceutical composition comprising, as an active ingredient, neural precursor cells differentiated from HLA homozygous human induced pluripotent stem cells (hiPSC-NPC), wherein, through the use of a homozygous type, immunorejection may be eliminated and stable therapeutic effects for stroke may be exhibited.